MEDICUS acquired by DOCTOLIB
Context
Doctolib executed a strategic acquisition of Medicus, a UK-based developer of clinical software for the National Health Service (NHS), marking its official entry into the United Kingdom. This transaction represents a key milestone in Doctolib's European expansion, adding the UK as its fifth operational market alongside France, Germany, Italy, and the Netherlands. The acquisition is driven by a shared mission to address systemic challenges within healthcare, particularly the increasing demand for care and the significant administrative burden placed on medical professionals. By integrating Medicus, Doctolib gains an immediate and strong foothold in the UK's primary care sector. Medicus is recognized for having developed the first new software for general practitioners in the NHS in over two decades, successfully disrupting a market dominated by two incumbents. The rationale behind the deal is to combine Medicus's deep understanding of the NHS and its user-centric platform with Doctolib's extensive technological expertise, particularly in artificial intelligence and scalable software solutions. The synergy is expected to accelerate the development and deployment of a more comprehensive product suite for UK GPs, focusing on innovations that simplify clinical documentation, automate workflows, and ultimately allow healthcare providers to dedicate more time to patient care.
MEDICUS, which reported an EBITDA margin of LOGIN in 2026, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the TMT (Tech, Media, Telecom) sector (14.8x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in TMT (Tech, Media, Telecom) market trends
Target
Medicus is a United Kingdom-based health technology company that has developed a next-generation clinical software platform for general practitioner (GP) surgeries operating within the National Health Service (NHS). The company distinguished itself by introducing the first new GP clinical software system to the NHS market in 25 years, challenging a long-standing duopoly of established providers. Its platform is specifically designed with and for British healthcare professionals, earning a reputation for its user-centric design, ease of use in daily operations, and close alignment with the needs of primary care teams. The software provides a comprehensive suite of functionalities, including patient scheduling, clinical documentation, care coordination, and patient follow-up. A key feature of the Medicus system is its native integration with the official NHS App, the digital portal used by millions of patients to access their health information and book appointments. This integration ensures seamless connectivity within the broader NHS digital ecosystem. In June 2025, the company's product received official validation from NHS England, formally opening the public health market for its innovative solution aimed at modernizing GP IT infrastructure and supporting a more collaborative, efficient healthcare workforce.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (GBP)
Similar deals in TMT (Tech, Media, Telecom)
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 06/2026 | CVC | CHESS.COM | UNITED STATES | Software | CVC Capital Partners has announced an investment in Chess.com, the world’s largest online chess platform, alongside General Atlantic, the company’s longstanding investor, which will remain a shareholder. The transaction marks CVC’s entry as an investor in Chess.com to support the platform’s continued development and its expansion within the global chess community. The investment reflects CVC’s strategy of backing companies operating at the intersection of sports, digital entertainment, online communities and consumer experiences |
| 06/2026 | ASYS | M-WORK | FRANCE | Software | The acquisition of m-work shifts Asys’s product perimeter from legacy time-and-attendance tracking into upstream collaborative workforce scheduling and hybrid physical asset optimization. Executed with follow-on programmatic M&A backing from CAPZA through its Growth Tech investment vehicle, this transaction accelerates Asys’s product roadmap by injecting native AI capabilities into its core scheduling engine to target pan-European corporate accounts. The industrial logic relies on immediate cross-sell dynamics, unlocking monetization opportunities for m-work’s module within Asys's established footprint of 1 |
| 05/2026 | LATTICE SEMICONDUCTOR | AMI | UNITED STATES | Software | Lattice Semiconductor has agreed to acquire AMI in a strategic transaction designed to create a comprehensive secure management and control platform for the technology industry. The acquisition is a key step in advancing Lattice's strategy to expand its market position in high-growth server, AI, and cloud applications. By combining Lattice's leadership in low-power programmable hardware (FPGAs) with AMI's deep expertise in platform firmware and infrastructure manageability software, the merged entity aims to offer integrated, system-level solutions |
| 05/2026 | OAKLEY CAPITAL INVESTMENTS | XTEL | BELGIUM | Software | Pan-European private equity investor Oakley Capital has entered into an agreement to acquire a majority equity stake in enterprise software provider XTEL. The transaction is being executed alongside existing shareholders Bain Capital and SilverTree Equity, with the latter remaining invested to actively support the company's next phase of growth. Evercore acted as the exclusive financial advisor to XTEL and the selling consortium throughout the transaction process. For Oakley Capital, the buyout is designed to leverage its extensive track record in backing European software champions to drive XTEL's international expansion into key growth markets such as Latin America and Asia-Pacific, while pursuing targeted M&A opportunities |
| 05/2026 | BREGAL SAGEMOUNT / ARDIAN | ENNOV | FRANCE | Software | The transaction represents a transition of ownership from a founder-led corporate structure to a sponsor-backed primary LBO. The core industrial rationale of the ownership transfer is to match the target's capital structure with its cross-border scaling ambitions, specifically accelerating market share gains in the high-volume North American life sciences software sector. The timing of the transaction reflects the inflection point where the target requires institutional private equity expertise and global capital to scale its commercial distribution network |
| 05/2026 | LEGALPLACE | LEGALSTART | France | Software | LegalPlace has completed the full acquisition of its historical and primary competitor, Legalstart, marking a major consolidation event within the French LegalTech landscape. The transaction was financed as part of a significant capital increase by LegalPlace, backed by a consortium of investors including Move Capital Fund I, XAnge, and Eurazeo. The purchase of Legalstart's shares was settled entirely in cash. This strategic merger unites two of the most recognized platforms dedicated to online services for entrepreneurs, which had for years competed directly in the same market segment |
| 05/2026 | PUBLICIS GROUPE | LIVERAMP | UNITED STATES | Software | Publicis Groupe has entered into a definitive agreement to acquire 100% of the share capital of US-based LiveRamp through an all-cash public tender offer. This landmark cross-border transaction represents Publicis' largest tech-driven acquisition since Epsilon, explicitly engineered to accelerate the group's digital capabilities in secure data co-creation, advanced data clean rooms, and agentic AI enterprise transformation. By internalizing LiveRamp's interoperable data collaboration platform and network, Publicis aims to combine these assets with its legacy data powerhouse Epsilon, its digital business transformation engine Publicis Sapient, and its proprietary Marcel platform |
| 04/2026 | LONG PATH PARTNERS | IDOX | UNITED KINGDOM | Software | Long Path Partners has declared its all-cash offer for Idox plc unconditional, completing the acquisition process. The transaction involves the transfer of 100% of the share capital of the London-listed software business to the U.S.-based investment manager. The acquisition is a high-conviction investment aligned with Long Path Partners' strategy of backing high-quality, durable software businesses with mission-critical roles in their respective industries. Idox fits the firm's profile of a cash-generative, stable business providing essential regulatory software |
| 04/2026 | AMADEUS | IDEMIA PUBLIC SECURITY | FRANCE | Software | The acquisition of Idemia Public Security (IPS) by Amadeus represents a transformational transaction, marking a significant milestone in the structured divestment strategy of Advent International. Strategically, this acquisition allows Amadeus to internalize world-class biometric capabilities, directly supporting its vision for a modernized and secure global travel infrastructure. The transaction follows a highly competitive auction process exclusively targeting industrial buyers, where the Spanish group successfully leveraged its strong pro forma balance sheet to outbid international competitors |
| 04/2026 | TURENNE CAPITAL | KIZEO | FRANCE | Software | The transaction involves the entry of Turenne Emergence into Kizeo’s capital, acquiring a ~20% minority stake through an equity investment of 10 million EUR. This growth LBO represents a strategic partnership aimed at accelerating the company's development trajectory over the next five years. The deal rationale is centered on supporting the target's ambitious growth plan, which includes doubling the firm's size through the expansion of its functional software coverage, pursuing international deployment, and evaluating potential external growth opportunities (buy-and-build) |
REFERENCES
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of MEDICUS by DOCTOLIB are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Target: medicus
Acquirer: doctolib